About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
K
Treating Metastatic or Recurrent Cervical Cancer With an Antibody-Drug Conjugate
By
Krishnansu Tewari
2 Videos
315 views
May 2, 2022
0 Comments
Login to view comments.
Click here to Login
Featured Video
20:09
AstraZeneca Oncology
Management Strategies for Anemia in First-line Maintenance Therapy f…
Feat.
D. Czel,
C. Arn
Featured Video
19:51
AstraZeneca Oncology
Management Strategies for Fatigue and Asthenia in First-line Mainten…
Feat.
D. Czel,
C. Arn
Related Content
AUTOPLAY
ON
27:04
Fengting Yan
Cancer Screening Molecular Tools
06:07
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Summary: "Key Updates in Gynecological Cancers"
Feat.
M. Raza Mirza
17:50
AdventHealth
Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…
Feat.
G. Sonpavde
04:02
Total Health
2024 Updates in Cervical Cancer
Feat.
T. Tillmanns
15:14
Brian Slomovitz
Update in Vulvar and Vaginal Cancer
07:56
Fengting Yan
Year in Review: Cervical Cancer
06:46
Total Health
Recent Highlights in Cervical Cancer
Feat.
B. Slomovitz
44:59
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course
Updates on Cervical and Endometrial Cancers
Feat.
K. Pennington
13:41
UCLA Health
2024 Updates in Locally Advanced Cervical Cancer
Feat.
D. Chase
05:31
Insights from 2024 SGO Annual Meeting
SGO 2024 Insights: "Impact of Maintenance Bevacizumab Following…
Feat.
M. Kuznicki
10:27
Robert McBane
2023 ISTH Insights: "The EVE Trial - Extending VTE Secondary Pr…
11:37
UCLA Health
Recurrent Cervical Cancer Updates
Feat.
R. Salani
11:10
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "KEYNOTE-A18 Study - Pembro + CRT for High-…
Feat.
D. Lorusso
12:21
Insights from 2024 ESGO Annual Meeting
ESGO 2024 Insights: "PARP Inhibitor Resistance Mechanisms in Gy…
Feat.
V. Heinzelmann-Schwarz
08:24
Hope Cottrill
Tisotumab Vedotin in Advanced or Recurrent Cervical Cancer
07:05
Insights from 2024 ESGO Annual Meeting
ESGO 2024 Insights: "Understanding and Targeting BRCA & HRD…
Feat.
V. Heinzelmann-Schwarz
23:38
Insights from 2023 IGCS Annual Meeting
IGCS 2023 Insights: "Is Immunotherapy Beating Stage 4B, Persist…
Feat.
N. Colombo
06:29
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "TEDOVA Trial - Neo-Epitope Based Vaccine …
Feat.
A. Leary
28:26
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2023
The Role of Immunotherapy and Targeted Therapy in GYN Cancers
Feat.
S. Gaillard
10:14
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024
Integrating Immunotherapy Into the Treatment of Cervical Cancer
Feat.
A. Wright
